How should minimally important change scores for the Patient‐Oriented Eczema Measure be interpreted? A validation using varied methods

por Howells, L., Ratib, S., Chalmers, J.R., Bradshaw, L., Thomas, K.S.
Publicado 2018

A Further Study of the Carcinogenic Properties of Ortho Hydroxy-Amines and Related Compounds by Bladder Implantation in the Mouse

por Bonser, Georgiana M., Bradshaw, L., Clayson, D. B., Jull, J. W.
Publicado 1956

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.

por Dabholkar, M, Bradshaw, L, Parker, R J, Gill, I, Bostick-Bruton, F, Muggia, F M, Reed, E
Publicado 1992

Do patient characteristics matter when calculating sample size for eczema clinical trials?

por Howells, L., Gran, S., Chalmers, J. R., Stuart, B., Santer, M., Bradshaw, L., Gaunt, D. M., Ridd, M. J., Gerbens, L. A. A., Spuls, P. I., Huang, C., Francis, N. A., Thomas, K. S.
Publicado 2021